Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study. Kaplan GG, Ma C, Charlton C, Kanji JN, et al. Gut 2022;71:1229-1231.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kaplan GG, Ma C, Charlton C, Kanji JN, et al. Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study. Gut 2022;71:1229-1231.
PMID: 34340997